{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:13:04Z","timestamp":1787497984034,"version":"build-2736575974"},"reference-count":30,"publisher":"Codon Publications","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.aller.2010.12.007","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T13:14:20Z","timestamp":1302873260000},"page":"356-361","source":"Crossref","is-referenced-by-count":26,"title":["Vitiligo and associated autoimmune disorders: A retrospective hospital-based study in Mumbai, India"],"prefix":"10.15586","volume":"39","author":[{"given":"S.A.","family":"Poojary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2010.12.007_bib0005","first-page":"749","article-title":"Pigmentary disorders","volume":"1","author":"Dhar","year":"2008"},{"key":"10.1016\/j.aller.2010.12.007_bib0010","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-3083.2007.02228.x","article-title":"Autoimmunity as an etiological factor in vitiligo","volume":"21","author":"Rezaei","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.aller.2010.12.007_bib0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-4632.2005.02651.x","article-title":"Vitiligo: autoimmunity and immune responses","volume":"45","author":"Sehgal","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.aller.2010.12.007_bib0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.aller.2010.12.007_bib0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000247164","article-title":"Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients","volume":"188","author":"Schallreuter","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.aller.2010.12.007_bib0030","first-page":"68","article-title":"High frequency of thyroid dysfunction in Indian patients with vitiligo","volume":"48","author":"Dave","year":"2003","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.aller.2010.12.007_bib0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4161\/derm.1.1.7306","article-title":"Vitiligo vulgaris and autoimmune diseases in Japan. A report from vitiligo clinic in Kyoto University Hospital","volume":"1","author":"Tanioka","year":"2009","journal-title":"Dermatoendocrinology"},{"key":"10.1016\/j.aller.2010.12.007_bib0040","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4103\/0378-6323.45144","article-title":"Clinical and sociodemographic study of vitiligo","volume":"74","author":"Shah","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.aller.2010.12.007_bib0045","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1684\/ejd.2009.0939","article-title":"Poly glandular autoimmune diseases in a dermatological clinical setting: vitiligo associated autoimmune diseases","volume":"20","author":"Amerio","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.aller.2010.12.007_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0019-5154.39733","article-title":"Thyroid dysfunction and thyroid antibodies in Iranian patients with vitiligo","volume":"53","author":"Moradi","year":"2008","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.aller.2010.12.007_bib0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000081479","article-title":"Relevance of thyroiditis and other autoimmune diseases in children with vitiligo","volume":"210","author":"Iacovelli","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.aller.2010.12.007_bib0060","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/jaut.1995.0009","article-title":"Associated autoimmunity in Addison's disease","volume":"8","author":"Zellisen","year":"1995","journal-title":"J Autoimmun"},{"key":"10.1016\/j.aller.2010.12.007_bib0065","first-page":"127","article-title":"Viral and autoimmune disease in endemic pemphigus foliaceus patients and their influence over the disease immunology","volume":"17","author":"Galarza","year":"2006","journal-title":"Folia Dermatol"},{"key":"10.1016\/j.aller.2010.12.007_bib0070","first-page":"157","article-title":"Association of alopecia areata, vitiligo and pemphigus vulgaris","volume":"61","author":"Inamdar","year":"1995","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.aller.2010.12.007_bib0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1346-8138.1995.tb03402.x","article-title":"Coexistence of vitiligo and morphea: a case report and review of literature","volume":"22","author":"Finkelstein","year":"1995","journal-title":"J Dermatol"},{"key":"10.1016\/j.aller.2010.12.007_bib0080","first-page":"37","article-title":"Vitiligo and disseminated discoid lupus erythematosus","volume":"33","author":"Khare","year":"1988","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.aller.2010.12.007_bib0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2249.2003.02089.x","article-title":"Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume","volume":"131","author":"Zettining","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.aller.2010.12.007_bib0090","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000249466","article-title":"Incidence and significance of organ specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo","volume":"171","author":"Betterle","year":"1985","journal-title":"Dermtologica"},{"key":"10.1016\/j.aller.2010.12.007_bib0095","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-0749.2005.00242.x","article-title":"Early disease onset and increased risk of other autoimmune diseases in familiar generalised vitiligo","volume":"18","author":"Laberge","year":"2005","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.aller.2010.12.007_bib0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/381134","article-title":"Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis","volume":"74","author":"Spritz","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.aller.2010.12.007_bib0105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/hmg\/11.6.661","article-title":"Mapping of an autoimmune susceptibility locus (AIS1) to chromosome 1p 31.3\u2013p32.2","volume":"11","author":"Alkhateeb","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.aller.2010.12.007_bib0110","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo associated multiple autoimmune disease","volume":"356","author":"Jin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aller.2010.12.007_bib0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1\u03b2 inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aller.2010.12.007_bib0120","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.4049\/jimmunol.175.4.2630","article-title":"IL-converting enzyme\/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients","volume":"175","author":"Stack","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.aller.2010.12.007_bib0125","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/1523-1747.ep12614826","article-title":"Molecular heterogeneity of the fourth component (C4) and its genes in vitiligo","volume":"99","author":"Vennekar","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.aller.2010.12.007_bib0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-0749.2004.00196.x","article-title":"CTLA-4 polymorphisms are associated with vitiligo in patients with concomitant autoimmune diseases","volume":"18","author":"Blomhoff","year":"2005","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.aller.2010.12.007_bib0135","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/sj.gene.6364243","article-title":"A single nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptiblity to generalised vitiligo","volume":"6","author":"Canton","year":"2005","journal-title":"Genes Immun"},{"key":"10.1016\/j.aller.2010.12.007_bib0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/gepi.1370020107","article-title":"Studies on vitiligo. I. Epidemiological profile in Calcutta, India","volume":"2","author":"Das","year":"1985","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.aller.2010.12.007_bib0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0019-5154.26928","article-title":"Vitiligo: clinical profiles in Vadodara, Gujarat","volume":"51","author":"Shajil","year":"2006","journal-title":"Ind J Dermatol"},{"key":"10.1016\/j.aller.2010.12.007_bib0150","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/0378-6323.32710","article-title":"Vitiligo: a part of a systemic autoimmune process","volume":"73","author":"Gopal","year":"2007","journal-title":"Ind J Dermatol Venereol Leprol"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054611001066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054611001066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T17:50:54Z","timestamp":1609437054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054611001066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0301054611001066"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2010.12.007","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}